CAT

895.97

+4.53%↑

GE

332.27

+4%↑

GEV.US

903.72

+4.34%↑

RTX

183.79

+3.33%↑

BA

221.14

+5.77%↑

CAT

895.97

+4.53%↑

GE

332.27

+4%↑

GEV.US

903.72

+4.34%↑

RTX

183.79

+3.33%↑

BA

221.14

+5.77%↑

CAT

895.97

+4.53%↑

GE

332.27

+4%↑

GEV.US

903.72

+4.34%↑

RTX

183.79

+3.33%↑

BA

221.14

+5.77%↑

CAT

895.97

+4.53%↑

GE

332.27

+4%↑

GEV.US

903.72

+4.34%↑

RTX

183.79

+3.33%↑

BA

221.14

+5.77%↑

CAT

895.97

+4.53%↑

GE

332.27

+4%↑

GEV.US

903.72

+4.34%↑

RTX

183.79

+3.33%↑

BA

221.14

+5.77%↑

Ocugen Inc

Затворен

1.23 3.36

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1.17

Максимум

1.24

Ключови измерители

By Trading Economics

Приходи

-1.5M

-19M

Продажби

1.7M

1.5M

EPS

-0.06

Марж на печалбата

-1,250.946

Служители

116

EBITDA

-987K

-17M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+712.61% upside

Дивиденти

By Acuity

Следващи печалби

31.07.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-193M

433M

Предишно отваряне

-2.13

Предишно затваряне

1.23

Ocugen Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

11.06.2026 г., 23:56 ч. UTC

Event

Vertex Pharmaceuticals announced clinical benefits of CASGEVY® for severe sickle cell disease. Shares are trading lower in after-market hours, within a typical trading range.

11.06.2026 г., 23:56 ч. UTC

Correlated Moves
ETF Constituents
Macro News

iShares MSCI Brazil ETF trades higher after President Trump's cancellation of military strikes against Iran, boosting global investor confidence.

11.06.2026 г., 23:56 ч. UTC

News

Monster Beverage shares higher in after-market trading following Bernstein's initiation of coverage with a Market Perform rating. The stock has gained over four consecutive sessions.

11.06.2026 г., 23:52 ч. UTC

Michigan Consumer Sentiment Report for June 2026 Forecasts Continued Decline at 46.0 Amid Economic Pressures and Inflation Concerns

11.06.2026 г., 23:52 ч. UTC

Investors Await Key U.S. Building Permits Report Amid Cautious Market Sentiment Ahead of June 16 Release

11.06.2026 г., 23:52 ч. UTC

Macro Event
News
Correlated Moves

The Australian Dollar has gained against the Singapore Dollar, supported by a slight decline in consumer inflation expectations and recent geopolitical developments.

11.06.2026 г., 23:51 ч. UTC

News

The iShares Core U.S. Aggregate Bond ETF is trading lower in after-market hours, reflecting concerns over inflation following a rise in the producer price index.

11.06.2026 г., 23:51 ч. UTC

Correlated Moves

Lam Research Corp is rising in after-market trading, supported by a broader market rally and strong momentum near the upper end of its one-month trading range.

11.06.2026 г., 23:51 ч. UTC

Correlated Moves

Costco Wholesale Corp shares are higher in after-market hours, supported by a rising Nasdaq 100 Index and positive sentiment in the consumer staples sector.

11.06.2026 г., 23:51 ч. UTC

Trip.com Group Ltd is higher in after-market hours, reflecting broader market gains. No specific company news was identified to explain this movement.

11.06.2026 г., 23:51 ч. UTC

ETF Constituents

Vanguard FTSE Europe ETF is trading lower in after-market hours, impacted by declines from holdings including HSBC and Diageo, despite a generally higher market.

11.06.2026 г., 23:51 ч. UTC

Marriott International Inc. shares declined in after-market hours following Thursday's close, with no specific news identified to explain the movement.

11.06.2026 г., 23:51 ч. UTC

PepsiCo Inc shares are higher in after-market hours, driven by a significant overall market trend. The stock remains below its 20-day moving average.

11.06.2026 г., 23:51 ч. UTC

Lululemon Athletica is trading lower in after-market hours, reflecting a decline since Thursday's close. It reached a session low earlier in the session.

11.06.2026 г., 23:51 ч. UTC

Correlated Moves
ETF Constituents
News
Social Media

SPDR S&P 500 ETF Trust rises in after-hours trading amid improved market sentiment and reduced geopolitical tensions in Iran, supported by strong performances from top holdings.

11.06.2026 г., 23:51 ч. UTC

Correlated Moves
ETF Constituents
News
Social Media

Invesco QQQ Trust Series I rises after hours, supported by a Nasdaq 100 rally driven by technology stocks and easing inflation concerns.

11.06.2026 г., 23:51 ч. UTC

ETF Constituents
Correlated Moves
Macro News

Global X Copper Miners ETF declines in after-market trading as top holdings BHP and Southern Copper Corporation show slight decreases.

11.06.2026 г., 23:51 ч. UTC

Correlated Moves

Microchip Technology Inc is rising in after-market trading, reflecting broader market trends amid the European Central Bank's recent interest rate hike.

11.06.2026 г., 23:51 ч. UTC

Social Media
Correlated Moves

Micron Technology is trading higher in after-market hours, supported by positive market trends and favorable social media sentiment ahead of upcoming earnings.

11.06.2026 г., 23:51 ч. UTC

Correlated Moves

The Nasdaq 100 Index is higher today, continuing its upward trend. Initial jobless claims rose unexpectedly, but this has not impacted the index's momentum.

11.06.2026 г., 23:51 ч. UTC

News

The United States Oil Fund LP is higher in after-market trading amid reports of explosions in Iran raising concerns over oil supply stability.

11.06.2026 г., 23:46 ч. UTC

Intuitive Surgical Inc. shares are higher in after-market trading, advancing modestly since Thursday's close despite remaining below the 20-day moving average.

11.06.2026 г., 23:46 ч. UTC

Oil (Brent) is trading roughly flat with no specific news identified. It remains 7.63% below its 20-day moving average, indicating weak performance.

11.06.2026 г., 23:46 ч. UTC

ETF Constituents
Correlated Moves

The Vanguard FTSE Developed Markets ETF is trading higher in after-market hours, buoyed by the European Central Bank's interest rate hike and strong performances from SAP and BP.

11.06.2026 г., 23:42 ч. UTC

Housing Starts Data Release on June 16, 2026 Expected at 1.44 Million Amid Mixed Economic Sentiment and Inflation Concerns

11.06.2026 г., 23:42 ч. UTC

U.S. Import Prices Expected to Rise Amid Inflation Concerns and Geopolitical Tensions Ahead of June 16 Release

11.06.2026 г., 23:42 ч. UTC

U.S. Export Prices Expected to Rise 1% MoM Amid Mixed Economic Sentiment and Geopolitical Tensions Ahead of June 16 Release

11.06.2026 г., 23:42 ч. UTC

Market Awaits May Housing Starts Data Amid Economic Uncertainties and Rising Costs.

11.06.2026 г., 23:42 ч. UTC

U.S. Building Permits Expected to Rise Slightly to 1.41 Million Amid Cautious Optimism Ahead of June Release

11.06.2026 г., 23:42 ч. UTC

Macro News
ETF Constituents

Investor sentiment towards the Consumer Staples Select Sector SPDR Fund improves in after-market trading, buoyed by macro developments and strong performances from key holdings.

Сравнение с други в отрасъла

Ценова промяна

Ocugen Inc Прогноза

Ценова цел

By TipRanks

712.61% нагоре

12-месечна прогноза

Среден 9.67 USD  712.61%

Висок 12 USD

Нисък 7 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Ocugen Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

6 ratings

6

Купи

0

Задържане

0

Продай

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.
help-icon Live chat